Although, to date, there are limited reports on the role of IMPase in cancer development and metastatic progression, we recently reported that the posttranscriptional repression of IMPA2, but not IMPA1, promotes metastatic progression in ccRCC [13]. This evidence concerns the gene IMPA2 and nonpapillary renal cell carcinoma.